GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » 1-Year ROIIC %

Curatis Holding AG (CHIX:CURNZ) 1-Year ROIIC % : -5.03% (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Curatis Holding AG's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was -5.03%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Curatis Holding AG's 1-Year ROIIC % or its related term are showing as below:

CHIX:CURNz's 1-Year ROIIC % is ranked worse than
57.31% of 862 companies
in the Drug Manufacturers industry
Industry Median: 1.43 vs CHIX:CURNz: -5.03

Curatis Holding AG 1-Year ROIIC % Historical Data

The historical data trend for Curatis Holding AG's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG 1-Year ROIIC % Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
1-Year ROIIC %
- -9.14 12.73

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
1-Year ROIIC % Get a 7-Day Free Trial - -9.14 3.73 12.73 -5.03

Competitive Comparison of Curatis Holding AG's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's 1-Year ROIIC % falls into.


;
;

Curatis Holding AG 1-Year ROIIC % Calculation

Curatis Holding AG's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -4.7854 (Jun. 2024) - -2.6565 (Jun. 2023) )/( 54.776 (Jun. 2024) - 12.425 (Jun. 2023) )
=-2.1289/42.351
=-5.03%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Curatis Holding AG  (CHIX:CURNz) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Curatis Holding AG 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines